Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma-Reference-Cited by-同舟云学术

Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma

Published:2014-01-22 Issue:6 Volume:74 Page:1752-1765
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Yan Fengting,Alinari Lapo,Lustberg Mark E.,Katherine Martin Ludmila,Cordero-Nieves Hector M.,Banasavadi-Siddegowda Yeshavanth,Virk Selene,Barnholtz-Sloan Jill,Bell Erica Hlavin,Wojton Jeffrey,Jacob Naduparambil K.,Chakravarti Arnab,Nowicki Michal O.,Wu Xin,Lapalombella Rosa,Datta Jharna,Yu Bo,Gordon Kate,Haseley Amy,Patton John T.,Smith Porsha L.,Ryu John,Zhang Xiaoli,Mo Xiaokui,Marcucci Guido,Nuovo Gerard,Kwon Chang-Hyuk,Byrd John C.,Chiocca E. Antonio,Li Chenglong,Sif Said,Jacob Samson,Lawler Sean,Kaur Balveen,Baiocchi Robert A.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapy;Cancer Letters;2024-10

2. Prevalence of S-methyl-5′-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer;American Journal of Surgical Pathology;2024-08-12

3. Targeting PRMT5 enhances the radiosensitivity of tumor cells grown in vitro and in vivo;Scientific Reports;2024-07-27

4. PRMT6 facilitates EZH2 protein stability by inhibiting TRAF6-mediated ubiquitination degradation to promote glioblastoma cell invasion and migration;Cell Death & Disease;2024-07-23

5. Regulation of RORα Stability through PRMT5-Dependent Symmetric Dimethylation;Cancers;2024-05-17